Richard Marshall

Chief Executive Officer at

Juvenescence Ltd.

Net worth: 22 417 $ as of 31/05/2026

59 year

76 connections

Health Technology

Consumer Services

Finance

Profile

Richard Marshall is Chief Executive Officer at Juvenescence Ltd. and Juvenescence Therapeutics Ltd. since 2023.
Since 2024, Dr. Marshall is an Independent Director at Serina Therapeutics, Inc. From 2019 to 2023, Dr. Marshall was SVP, Global Head-Respiratory & Immunology at AstraZeneca PLC.
From 2002 to 2018, Dr. Marshall was Vice President-Fibrosis Research & Development at GSK Plc.
Dr. Marshall completed undergraduate and doctorate degrees at University College London.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.08%	17/06/2026	12,183 ( 0.08% )	22 417 $	31/05/2026

Richard Marshall active positions

Companies	Position	Start
Juvenescence Ltd. Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company	Chief Executive Officer	16/01/2023

All active positions of Richard Marshall

Former positions of Richard Marshall

Companies	Position	End
ASTRAZENECA PLC	Corporate Officer/Principal	01/01/2023
GSK PLC	Corporate Officer/Principal	01/01/2018

See the detail of Richard Marshall's experience

Training of Richard Marshall

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Marshall's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
University College London University College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Juvenescence Ltd. Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company	Finance